UNIVERSITY OF CALIFORNIA

,

LOS ANGELES

UCLA
SANTA BARBARA • SANTA CRUZ

BERKELEY • DAVIS • IRVINE • LOS ANGELES • MERCED • RIVERSIDE • SANDIEGO • SANFRANCISCO

OFFICE OF THE HUMAN RESEARCH PROTECTION PROGRAM 11000 KINROSS AVENUE, SUITE 211 LOS ANGELES, CA 90095-1694

May16,2013 Peter M, Heimlich 3630 River Hollow Run Duluth, GA 30096 Dear Mr. Heimlich, Thank you for detailed letter of May 6, 2013, regarding UCLA's 2002/2003 investigation of the Heimlich Institute's "malariatherapy" research in China. After conferring with my colleagues I can assure you that UCLA's review, taking place over more than 18 months, was thorough and exhaustive and based on information available at the time. The findings did not support either the Heimlich Institute's or Dr. Heimlich's claims that Dr. John Fahey was directly involved in developing or conducting the clinical trial you reference. Rather, UCLA found that Dr. Fahey was involved in evaluating data and biological samples brought from China to UCLA by an individual participating in the Fogarty International Program, and that this did, in fact, constitute human subjects research that had not been reviewed and approved as required by federal regulation and campus policy. The campus followed through on its commitment to report Dr. Fahey's violation of federal and campus policies to the U.S. Department of Health and Human Services, and the then Executive Vice Chancellor took steps to ensure that campus researchers were reminded of polices governing human subjects research. Dr. Fahey retired from the University in 2008 and no longer lives in the state. The University no longer has any jurisdiction over Dr. Fahey or the other parties referenced in your letter. It is regrettable that the Heimlich Institute and Dr. Heimlich continue to exaggerate UCLA's involvement in malariatherapy research. Nevertheless, after carefully considering your letter, we have determined that it is not necessary, appropriate, or useful to re-open the past 10 year old investigation or initiate another review. We consider this case closed. Once again, thank you for your letter and expressing your concerns.

S;!l I:_ZJ
Sharon K. Friend, MS, CIP Director Office of the Human Research Protection Program cc: UCLA Chancellor Gene Block UCLA Board of Regent Chairman Sherry Lansing

Sign up to vote on this title
UsefulNot useful